fig1

Figure 1. Schematic representation of the network for the prevention and management of retinal adverse outcomes in subjects with diabetes treated with anticancer drugs. Diabetologists and oncologists, the leading figures of the team, collaborate with ophthalmologists and pharmacologists to prevent or treat retinal injury related to cancer therapies, in order to mitigate visual impairment and loss.